In Brief: Syntex
Executive Summary
Syntex: New name of the company's Palo Alto-based operations is Roche Bioscience, effective July 5, reflecting its acquisition in 1994 by Roche Holding Ltd. The organization's two business units will focus on neurobiology, particularly peripheral blood system disorders, and cell biology addressing musculoskeletal and autoimmune diseases, the company says. Syntex currently employs 1,800 people in Palo Alto; by early July, the census will drop to approximately 1,000 employees...